Oxidoreductase (1. ) (e.g., Luciferase) Patents (Class 435/189)
  • Patent number: 7785850
    Abstract: The present invention relates to a process for heterologous expression and large-scale production of functionally active enzyme trypanothione reductase of Leishmania donovani in prokaryotic system.
    Type: Grant
    Filed: November 23, 2004
    Date of Patent: August 31, 2010
    Assignee: Council of Scientific and Industrial Research
    Inventors: Neena Goyal, Mukul Kumar Mittal
  • Patent number: 7785851
    Abstract: A mutant protein having diaphorase activity is provided. A mutant protein includes an amino acid sequence obtained by deletion, replacement, addition, or insertion of at least one amino acid residue of a native-form amino acid sequence of SEQ. ID. No. 1, wherein the mutant protein has diaphorase activity with an enzyme activity of 245 or more.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: August 31, 2010
    Assignee: Sony Corporation
    Inventors: Yoshio Goto, Taiki Sugiyama, Yuichi Tokita, Hideyuki Kumita, Jusuke Shimura, Hideki Sakai, Takashi Tomita
  • Publication number: 20100205754
    Abstract: Modified CueO having excellent enzymatic activity and a composition for dyeing keratin fiber which contains the enzyme. A recombinant protein having an enzymatic activity for oxidizing p-phenylenediamine, the protein is obtained by removing from CueO at least one member selected from the group consisting of helix 5, helix 6, and helix 7; and the composition for dyeing keratin fiber containing the recombinant protein and an oxidation dye.
    Type: Application
    Filed: April 14, 2006
    Publication date: August 19, 2010
    Applicants: NATIONAL UNIVERSITY CORPORATION KANAZAWA UNIVERSIT, MANDOM CORPORATION
    Inventors: Kaori Otsuka, Yoshio Tsujino, Yusuke Konno, Shinji Kurose, Kunishige Kataoka, Takeshi Sakurai
  • Publication number: 20100203614
    Abstract: This disclosure relates to the polynucleotide sequences of SEQ ID NO: 1 and SEQ ID NO: 4, and to the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 3, and to novel fatty aldehyde reductase enzymes provided by the same.
    Type: Application
    Filed: February 12, 2010
    Publication date: August 12, 2010
    Applicant: Utah State University
    Inventors: Brad Wahlen, Brett Barney, Lance Seefeldt
  • Patent number: 7771977
    Abstract: Disclosed is a protein selected from: (1) a protein comprising the amino acid sequence of SEQ ID NO: 1 in the Sequence Listing; (2) a protein comprising the amino acid sequence of SEQ ID NO: 1 in the Sequence Listing with the deletion, addition, insertion and/or substitution of one or more amino acid residues, and having an alkane polyol dehydrogenase activity; or (3) a protein comprising an amino acid sequence having 80% or more identity with the amino acid sequence of SEQ ID NO: 1 in the Sequence Listing, and having an alkane polyol dehydrogenase activity. Also disclosed is a process for producing an alcohol, a ketone, an optically-active alcohol, dihydroxyacetone or a derivative thereof, using the protein.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: August 10, 2010
    Assignee: National University Corporation Nara Institute of Science and Technology
    Inventors: Keiko Onodera, Yoshiki Tani
  • Publication number: 20100199365
    Abstract: The present invention relates to polynucleotides from Helobdella robusta, Laccaria bicolor, Lottia gigantea, Microcoleus chthonoplastes, Monosiga brevicollis, Mycosphaerella fijiensis, Mycospaerella graminicola, Naegleria gruberi, Nectria haematococca, Nematostella vectensis, Phycomyces blakesleeanus, Trichoderma resii, Physcomitrella patens, Postia placenta, Selaginella moellendorffii and Microdochium nivale, which code for desaturases and which can be employed for the recombinant production of polyunsaturated fatty acids. The invention furthermore relates to vectors, host cells and transgenic nonhuman organisms which comprise the polynucleotides according to the invention, and to the polypeptides encoded by the polynucleotides. The invention furthermore relates to antibodies against the polypeptides according to the invention.
    Type: Application
    Filed: July 30, 2008
    Publication date: August 5, 2010
    Applicant: BASF Plant Science GmbH
    Inventors: Toralf Senger, Jörg Bauer
  • Publication number: 20100196986
    Abstract: There is provided an anti-fouling composition comprising (i) a surface coating material; (ii) (a) a first enzyme; and (b) a first substrate, wherein action of the first enzyme on the first substrate provides a second substrate (iil) a second enzyme, wherein the second enzyme is encapsulated in a silicate, and wherein said second enzyme generates an anti-foulant compound when acting on said second substrate.
    Type: Application
    Filed: February 5, 2010
    Publication date: August 5, 2010
    Applicant: Danisco A/S
    Inventors: Brian Sogaard Laursen, Jakob Broberg Kristensen
  • Publication number: 20100197514
    Abstract: The present invention relates to a protein crystal of at least one binding site of a human aromatase. The present invention also relates to a fully processed human cytochrome P450 aromatase and a protein crystal thereof. The present invention further relates to methods of making and using the aromatase and the protein crystal thereof.
    Type: Application
    Filed: March 29, 2010
    Publication date: August 5, 2010
    Applicant: HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE, INC.
    Inventor: Debashis GHOSH
  • Publication number: 20100197519
    Abstract: Methods for the evolution of NADPH specific ketol-acid reductoisomerase enzymes to acquire NADH specificity are provided. Specific mutant ketol-acid reductoisomerase enzymes isolated from Pseudomonas that have undergone co-factor switching to utilize NADH are described.
    Type: Application
    Filed: December 15, 2009
    Publication date: August 5, 2010
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Yougen Li, Der-Ing Liao, Mark J. Nelson, Daniel P. Okeefe
  • Publication number: 20100197503
    Abstract: Compositions and methods for conferring hydroxyphenyl pyruvate dioxygenase (HPPD) herbicide resistance or tolerance to plants are provided. Compositions include amino acid sequences, and variants and fragments thereof, for mutant HPPD polypeptides. Nucleic acids that encode the mutant HPPD polypeptides are also provided. Methods for conferring herbicide resistance or tolerance, particularly resistance or tolerance to certain classes of herbicides that inhibit HPPD, in plants are further provided. Methods are also provided for selectively controlling weeds in a field at a crop locus and for the assay, characterization, identification and selection of the mutant HPPDs of the current invention that provide herbicide tolerance.
    Type: Application
    Filed: January 22, 2010
    Publication date: August 5, 2010
    Inventors: Timothy Robert Hawkes, Michael Phillip Langford, Russell Colin Viner, Bernardus Theodorus Maria Vernooij, Richard Dale
  • Publication number: 20100196580
    Abstract: The present invention relates to plants, seeds and products derived thereof, in particular to Brassica plants, seeds products derived thereof, that have mutant sequences conferring high oleic acid profile on the seed oil. More particularly, the invention relates to mutant delta-12 fatty acid desaturase sequences, also referred to herein as FAD2 sequences, in such plants which confer high oleic acid profile on the seed oil.
    Type: Application
    Filed: January 11, 2008
    Publication date: August 5, 2010
    Applicants: MONSANTO SAS, DEUTSCHE SAATVEREDELUNG AG
    Inventors: Jean-Pierre Despeghel, Kunsheng Wu, Heinrich Busch
  • Patent number: 7767431
    Abstract: The present invention relates to the fields of microbiology and microbial genetics. More specifically, the invention relates to novel bacteria strains and processes employing these strains for the fermentative production of amino acids such as threonine.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: August 3, 2010
    Assignee: Archer-Daniels-Midland Company
    Inventors: Hungming J. Liaw, Jill S. Bradshaw, Yueqin Yang, Weiying Mao
  • Publication number: 20100190219
    Abstract: The present invention provides genetically engineered microbial strains, in particular genetically engineered yeast strains, that produce at least 0.5 mg per g CDW of a sphingoid base according to Formula I or a salt or ester thereof. The present invention provides a method to obtain genetically engineered microbial strains producing at least 0.5 mg per g CDW of a sphingoid base according to Formula I or a salt or ester thereof.
    Type: Application
    Filed: May 11, 2007
    Publication date: July 29, 2010
    Applicant: COSMOFERM B. V.
    Inventors: Steffen Schaffer, Marco Alexander Van Den Berg, Daniel Boergel, Thomas Hueller
  • Publication number: 20100189706
    Abstract: The invention provides polypeptides having a lignocellulolytic activity, e.g., a glycosyl hydrolase, a cellulase, an endoglucanase, a cellobiohydrolase, a beta-glucosidase, a xylanase, a mannanse, a xylosidase (e.g., a ?-xylosidase), an arabinofuranosidase, and/or a glucose oxidase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention provides polypeptides that can enzymatically process (hydrolyze) sugarcane bagasse, i.e., for sugarcane bagasse degradation, or for biomass processing, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. In one embodiment, the invention provides thermostable and thermotolerant forms of polypeptides of the invention.
    Type: Application
    Filed: January 30, 2008
    Publication date: July 29, 2010
    Inventors: Cathy Chang, Justin T. Stege, Nahla Aboushadi, Gordana Djordjevic, Ellen Burke, Peter Luginbuhl, Mark Dycaico, Toby Richardson, John Poland, Ying Hefner, Stacy Marie Miles
  • Publication number: 20100190196
    Abstract: A novel D-serine quantification method that can overcome various disadvantages of a conventional D-serine quantification method; a novel enzyme that can be used in the D-serine quantification method; a gene encoding the enzyme; and the like. Specifically, a novel D-serine dehydratase including (a) a protein having an amino acid sequence set forth in SEQ ID NO: 1 or (b) a protein having an amino acid sequence homologous to the amino acid sequence set forth in SEQ ID NO: 1 and having a D-serine dehydratase activity; and a D-serine quantification method including the steps of reacting a sample with the enzyme, quantifying ammonia or pyruvic acid produced by the reaction, and calculating the amount of D-serine in the sample based on a value produced by the quantification.
    Type: Application
    Filed: October 16, 2007
    Publication date: July 29, 2010
    Applicant: National University Corporation Nagoya University
    Inventors: Tohru Yoshimura, Tomokazu Ito
  • Publication number: 20100189707
    Abstract: The present invention provides stable compositions comprising a perhydrolase enzyme, a hydrogen peroxide source, and an ester substrate that efficiently generate aqueous peracid solutions. The generated peracid solutions are suitable for decontaminating and/or sanitizing a wide range of materials and equipment contaminated with pathogens or toxic chemicals. In one preferred embodiment, the stable composition comprises an acyl transferase enzyme, sodium percarbonate, and propylene glycol diacetate, and is stable for 30 days or longer. Upon addition to water, the composition is activated and generates an aqueous solution with a high ratio of peracetic acid to acetic acid.
    Type: Application
    Filed: May 5, 2008
    Publication date: July 29, 2010
    Inventor: Christopher C. Barnett
  • Patent number: 7763283
    Abstract: Biocompatible materials that have the ability to release nitric oxide (NO) in situ at the surface-blood interface when in contact with blood. The materials which may be polymers (e.g., polyurethane, poly(vinyl chloride), silicone rubbers), metals, such as stainless steel, carbon, and the like are provided with biocatalysts or biomimetic catalysts on their surface that have nitrite, nitrate, and/or nitrosothiol-reducing capability. Illustratively, the catalysts are adsorbed or immobilized at the surface of the material. The catalysts can act on endogenous nitrite, nitrate, or nitrosothiols within the blood creating a local increase in the NO levels at the surface of the material. An illustrative enzymatic biocatalyst is mammalian xanthine oxidase. In another illustrative embodiment, a biomimetic catalyst is a copper (Cu(II)-ligand complex, e.g. dibenzo[e,k]-2,3,8,9-tetraphenyl-1,4,7,10-tetraaza-cyclododeca-1,3,7,9-tetraene. In some cases, lipophilic salts of nitrite/nitrate (e.g.
    Type: Grant
    Filed: September 19, 2006
    Date of Patent: July 27, 2010
    Assignees: The Regents of The University of Michigan, Accord Biomaterials, Inc.
    Inventors: Melissa M. Batchelor, Bong Kyun Oh, Mark E. Meyerhoff
  • Patent number: 7763447
    Abstract: Succinic acid is produced by allowing a bacterium modified to enhance fumarate reductase activity or cell preparation thereof to react with an organic raw material in a reaction solution containing one of a carbonate ion, a bicarbonate ion, and carbon dioxide gas to generate succinic acid. More preferably, succinic acid is produced by allowing a bacterium modified to enhance activities of fumarate reductase and pyruvate carboxylase and decrease lactate dehydrogenase activity or cell preparation thereof to react with an organic raw material in a reaction solution containing one of a carbonate ion, a bicarbonate ion, and carbon dioxide gas to generate succinic acid. Succinic acid is obtained by collecting the produced succinic acid.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: July 27, 2010
    Assignee: Ajinomoto Co., Inc.
    Inventors: Makoto Murase, Ryusuke Aoyama, Miki Ikuta, Kenji Yamagishi, Mika Moriya, Jun Nakamura, Hiroyuki Kojima
  • Publication number: 20100186109
    Abstract: It is a subject of this invention to isolate a gene group of enzymes involved in the biosynthesis of vitamin E of Para rubber tree, and to determine the base sequence of each gene. According to this invention, genes encoding enzymes involved in the vitamin E biosynthesis were isolated from Para rubber tree and the base sequences of these genes were determined. Since vitamin E is an antioxidant existing in nature, it is expected that transformation of a plant by using the genes obtained in the invention would result in an increase in the vitamin E content of the plant and, in its turn, contribute to the prevention of rubber from aging.
    Type: Application
    Filed: March 19, 2008
    Publication date: July 22, 2010
    Applicants: BRIDGESTONE CORPORATION, Badan Pengkajian Dan Penerapan Teknologi
    Inventors: Tomoki Sando, Norie Watanabe, Koichiro Tamaizumi, Eiichiro Fukuzaki, Akio Kobayashi, Haska Nadirman, Purbowasito Wahyu
  • Publication number: 20100184185
    Abstract: The invention relates to the nucleotide and amino acid sequences, and to the activity and use, of the luciferases LuAL, Lu164, Lu16, Lu39, Lu45, Lu52 and Lu22.
    Type: Application
    Filed: October 22, 2007
    Publication date: July 22, 2010
    Inventors: Stefan Golz, Bernd Kalthof, Svetlana Markova, Ludmila Frank, Eugene Vysotski
  • Publication number: 20100184186
    Abstract: An isolated R. microporus laccase, a nucleic acid encoding the laccase, and a method of preparing it in a cell.
    Type: Application
    Filed: January 22, 2010
    Publication date: July 22, 2010
    Applicant: Academia Sinica
    Inventors: Po-Ting Chen, Chii-Gong Tong, Tuan-Hua David Ho, Su-May Yu
  • Publication number: 20100186114
    Abstract: The present invention relates to nucleic acids encoding flavonoid biosynthetic enzymes, flavonoid-regulating transcription factors and a flavonoid-specific membrane transporter in plants, and the use thereof for the modification of flavonoid biosynthesis in plants. The present invention also relates to constructs and vectors including such nucleic acids, and related polypeptides. More particularly, the protein involved in flavonoid biosynthesis is selected from the group consisting of: MADS box factor, WRKY box factor, MYC factor, TT1, HLH factor, MYB factor, FMT, UG3E, GST, OMT, RT, CYTb5, laccase, and ABC transporter proteins, and functionally active fragments and variants thereof.
    Type: Application
    Filed: June 25, 2008
    Publication date: July 22, 2010
    Applicant: AGRICULTURE VICTORIA SERVICES PTY LTD.
    Inventors: German Spangenberg, Aidyn Mouradov
  • Patent number: 7759543
    Abstract: Nucleotide sequences mediating male fertility in plants are described, with DNA molecule and amino acid sequences set forth. Promoter sequences and their essential regions are also identified. The nucleotide sequences are useful in mediating male fertility in plants. In one such method, the homozygous recessive condition of male sterility causing alleles is maintained after crossing with a second plant, where the second plant contains a restoring transgene construct having a nucleotide sequence which reverses the homozygous condition. The restoring sequence is linked with a hemizygous sequence encoding a product inhibiting formation or function of male gametes. The maintainer plant produces only viable male gametes which do not contain the restoring transgene construct. Increase of the maintainer plant is also provided by self-fertilization, and selection for seed or plants which contain the construct.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: July 20, 2010
    Assignee: Pioneer Hi-Bred International, Inc.
    Inventors: Marc Albertsen, Tim Fox, Gary Huffman, Mary Trimnell, Youngzhon Wu, Howard Hershey
  • Patent number: 7759544
    Abstract: Nucleotide sequences mediating male fertility in plants are described, with DNA molecule and amino acid sequences set forth. Promoter sequences and their essential regions are also identified. The nucleotide sequences are useful in mediating male fertility in plants. In one such method, the homozygous recessive condition of male sterility causing alleles is maintained after crossing with a second plant, where the second plant contains a restoring transgene construct having a nucleotide sequence which reverses the homozygous condition. The restoring sequence is linked with a hemizygous sequence encoding a product inhibiting formation or function of male gametes. The maintainer plant produces only viable male gametes which do not contain the restoring transgene construct. Increase of the maintainer plant is also provided by self-fertilization, and selection for seed or plants which contain the construct.
    Type: Grant
    Filed: September 22, 2009
    Date of Patent: July 20, 2010
    Assignee: Pioneer Hi-Bred International, Inc
    Inventors: Marc Albertsen, Tim Fox, Gary Huffman, Mary Trimnell, Youngzhon Wu, Howard Hershey
  • Patent number: 7754470
    Abstract: Compositions and methods are provided for bioremediation of toxic metals.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: July 13, 2010
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: A. C. Matin, Yoram Barak, David F. Ackerley
  • Publication number: 20100173342
    Abstract: The present invention relates to a biomarker and a method for determining an oxidative stress level in a biological sample, which employs co-factor-dependent oxidative stress parameters, as well as a kit adapted for carrying out such a method. Preferably the co-factor is tetrahydrobiopterin.
    Type: Application
    Filed: May 30, 2008
    Publication date: July 8, 2010
    Inventor: Klaus Michael WEINBERGER
  • Publication number: 20100173427
    Abstract: Methods, compositions and kits are disclosed directed at levetiracetam derivatives, immunogens, signal generating moieties, antibodies that bind levetiracetam and immunoassays for detection of levetiracetam.
    Type: Application
    Filed: October 22, 2009
    Publication date: July 8, 2010
    Inventors: Johnny Jose Valdez, Byung Sook Moon, Ki Chung, Alejandro A. Orozco
  • Publication number: 20100175148
    Abstract: Isolated nucleic acid fragments and recombinant constructs comprising such fragments encoding delta-9 elongases along with a method of making long-chain polyunsaturated fatty acids (PUFAs) using these delta-9 elongases in plants.
    Type: Application
    Filed: March 17, 2010
    Publication date: July 8, 2010
    Applicant: E. I. DU PONT DE NEMOURS AND COMPANY
    Inventors: Howard Glenn Damude, Brian McGonigle, Quinn Qun Zhu, Zhixiong Xue
  • Publication number: 20100173343
    Abstract: A method for the determination of 1,5-anhydroglucitol, characterized by using any one of the following proteins (a) to (c): (a) a protein which comprises an amino acid sequence depicted in SEQ ID NO:2; (b) a protein which comprises an amino acid sequence having the deletion, substitution and/or addition of one or several amino acid residues in the amino acid sequence depicted in SEQ ID NO:2 and which has a sorbose dehydrogenase activity; and (c) a protein which comprises an amino acid sequence having at least 60% sequence homology to the amino acid sequence depicted in SEQ ID NO:2 and which has a sorbose dehydrogenase activity.
    Type: Application
    Filed: June 22, 2007
    Publication date: July 8, 2010
    Applicant: IDEKA FOOD RESEARCH CO., LTD
    Inventor: Emi Ishimaru
  • Publication number: 20100166723
    Abstract: Compositions and methods for conferring nematicidal activity to bacteria, plants, plant cells, tissues and seeds are provided. Compositions including a coding sequence for nematicidal polypeptides are provided. The coding sequences can be used in DNA constructs or expression cassettes for transformation and expression in plants and bacteria. Compositions also include transformed bacteria, plants, plant cells, tissues, and seeds. In particular, isolated nematicidal nucleic acid molecules are provided. Additionally, amino acid sequences corresponding to the polynucleotides are encompassed. In particular, the present invention provides for isolated nucleic acid molecules including nucleotide sequences encoding the amino acid sequence shown in SEQ ID NO:4, 5, 8, 9, 13, 14, 47, 48, or 49, the nucleotide sequence set forth in SEQ ID NO:1, 2, 3, 6, 7, 10, 11, 12, 15, 45, or 46, as well as variants and fragments thereof.
    Type: Application
    Filed: December 15, 2009
    Publication date: July 1, 2010
    Applicant: ATHENIX CORPORATION
    Inventors: Cheryl L. Peters, Brian Vande Berg, Brian Carr, Julia T. Daum, Vadim Beilinson, Sandra Volrath, Candace Poutre, Kimberly Sampson, Theodore Kahn
  • Publication number: 20100168231
    Abstract: The use of an enzyme as a research tool for acne, by identifying a compound for the treatment of acne and/or any disorder associated with cutaneous hyperseborrhoea.
    Type: Application
    Filed: January 5, 2010
    Publication date: July 1, 2010
    Applicant: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Laurent Lamy, Michel Rivier, Gérard Feraille
  • Publication number: 20100167311
    Abstract: In Cu-containing nitrite reductase from Alcaligenes faecalis S-6 the axial methionine ligand of the type 1 site was replaced (M150G) to make the copper atom accessible to external ligands that might affect the enzyme's catalytic activity. The type-1 site optical spectrum of M150G (A460/A600=0.71) differs significantly from that of the native nitrite reductase (A460/A600=1.3). The reduction potential of the type-1 site of nitrite reductase M150G (EM=312?5 mV versus hydrogen) is higher than that of the native enzyme (EM=213?5 mV). M150G has a lower catalytic activity (kcat=133?6 s?1) than the wild-type nitrite reductase (kcat=416?10?s 1). The binding of external ligands to M150G restores spectral properties, reduction potential (EM<225 mV), and catalytic activity (kcat=374?28 s?1). Also the M150H (A460/A600=7.7, EM=104?5 mV, kcat=0.099?0.006 s?1) and M150T (A460/A600=0.085, EM=340?5 mV, kcat=126?2 s?1) variants were characterized to compare their properties with those of M150G.
    Type: Application
    Filed: February 8, 2007
    Publication date: July 1, 2010
    Inventors: Gerard W. Canters, Hein Jakob Wijma, Michael Murphy, Iain Macpherson
  • Patent number: 7745186
    Abstract: The present invention relates to novel ribulose-1,5-bisphosphate carboxylase/oxygenase polypeptides and the polynucleotides that encode them. The invention also provides related host cells and methods.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: June 29, 2010
    Assignee: Codexis, Inc.
    Inventors: Ranjini Chatterjee, Michelle M. Chen, Ranjan Patnaik, Stephen L. Schmidt
  • Patent number: 7745177
    Abstract: The present invention provides a method for manufacturing xylitol with high-yield and high-productivity by using a xylitol dehydrogenase-deficient mutant of xylitol producing microorganism. This goal is achieved through modification of the metabolic pathway of the xylitol producing microorganism, preferably a natural xylose-assimilating yeasts and fungi, by disrupting or inactivating the expression of desired genes.
    Type: Grant
    Filed: February 22, 2007
    Date of Patent: June 29, 2010
    Assignees: Korea Advanced Institute of Science and Technology, LPBIO Co., Ltd.
    Inventors: Jung-Hoe Kim, Byoung-Sam Ko
  • Patent number: 7741089
    Abstract: The invention provides laccases, polynucleotides encoding these enzymes, the use of such polynucleotides and polypeptides. In one aspect, the invention relates to the enzymatic production of nootkatone by way of the conversion of valencene using proteins having a laccase activity, e.g., a novel laccase of the invention. In one aspect, the invention provides methods of depolymerizing lignin, e.g., in a pulp or paper manufacturing process, using a polypeptide of the invention. In another aspect, the invention provides methods for oxidizing products that can be mediators of laccase-catalyzed oxidation reactions, e.g., 2,2-azinobis-(3-ethylbenzthiazoline-6-sulfonate) (ABTS), 1-hydroxybenzotriazole (HBT), 2,2,6,6-tetramethylpiperidin-1-yloxy (TEMPO), dimethoxyphenol, and the like.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: June 22, 2010
    Assignee: Verenium Corporation
    Inventors: Tim Hitchman, Dan E. Robertson, Masao Hiraiwa, Yoko Phillips, Kevin A. Gray
  • Publication number: 20100151554
    Abstract: The present invention provides an enzyme composition and a method for treating coal using the enzyme composition. The enzyme composition includes at least one enzyme, coenzyme and ammonium acetate, wherein the enzyme can be laccase-isozyme, pyruvate dehydrogenase, dihydrolipoyl transacetylase, and dihydrolipoyl dehydrogenase, and the coenzyme can be CoA, CoA-SH, thiamine pyrophosphate, lipoic acid, flavin adenine dinucleotide, and nicotinamide adenine dinucleotide. In addition, the method of the present invention includes treating the coal with the enzyme composition for more than 72 hours.
    Type: Application
    Filed: December 12, 2009
    Publication date: June 17, 2010
    Applicant: Ein Int'l Co. Ltd.
    Inventors: Min-Cheng Wang, Raphael Chiou
  • Publication number: 20100154080
    Abstract: The present invention is related to isolated polynucleotides encoding a delta-8 desaturase, delta-8 desaturases encoded by the isolated polynucleotides, expression vectors containing the isolated polynucleotides, host cells containing the expression vectors and methods for producing delta-8 desaturases and polyunsaturated fatty acids.
    Type: Application
    Filed: October 6, 2009
    Publication date: June 17, 2010
    Applicant: ABBOTT LABORATORIES
    Inventors: Tapas Das, Pradip Mukerji, Padmavathy Krishnan, Suzette L. Pereira
  • Publication number: 20100151534
    Abstract: The present disclosure provides engineered ketoreductase enzymes having improved properties as compared to a naturally occurring wild-type ketoreductase enzyme. Also provided are polynucleotides encoding the engineered ketoreductase enzymes, host cells capable of expressing the engineered ketoreductase enzymes, and methods of using the engineered ketoreductase enzymes to synthesize a variety of chiral compounds. The engineered ketoreductase polypeptides are optimized for catalyzing the conversion of N,N-dimethyl-3-keto-3-(2-thienyl)-1-ketopropanamine to (S)—N,N-dimethyl-3-hydroxy-3-(2-thienyl)-1-propanamine.
    Type: Application
    Filed: August 27, 2009
    Publication date: June 17, 2010
    Applicant: CODEXIS, INC.
    Inventors: Christopher Savile, John M. Gruber, Emily Mundorff, Gjalt Huisman, Steven James Collier
  • Patent number: 7736884
    Abstract: The present invention relates to the construction and engineering of cells, more particularly microorganisms for producing PUFAs with four or more double bonds from non-fatty acid substrates through heterologous expression of an oxygen requiring pathway. The invention especially involves improvement of the PUFA content in the host organism through fermentation optimization, e.g. decreasing the temperature and/or designing an optimal medium, or through improving the flux towards fatty acids by metabolic engineering, e.g. through over-expression of fatty acid synthases, over-expression of other enzymes involved in biosynthesis of the precursors for PUFAs, or codon optimization of the heterologous genes, or expression of heterologous enzymes involved in the biosynthesis of the precursor for PUFAs.
    Type: Grant
    Filed: June 6, 2005
    Date of Patent: June 15, 2010
    Assignee: Fluxome Sciences A/S
    Inventors: Nina Katarina Gunnarsson, Jochen Forster, Jens Bredal Nielsen
  • Patent number: 7736882
    Abstract: Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microorganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary for converting the intermediate into isopentenyl pyrophosphate. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: June 15, 2010
    Assignee: The Regents of the University of California
    Inventors: Jay D. Keasling, Vincent J. J. Martin, Douglas J. Pitera, Seon-Won Kim, Sydnor T. Withers, III, Yasuo Yoshikuni, Jack Newman, Artem Valentinovich Khlebnikov
  • Publication number: 20100143942
    Abstract: A method of detection of an analyte in which (i) a protein comprising a moiety capable of binding the analyte and a fluorescent label is contacted with a medium suspected of containing the analyte; (ii) the analyte, if present, binds to the moiety; (iii) the protein is subjected to incident radiation to excite the protein and induce intrinsic emission therefrom; whereby the intrinsic emission from the protein is converted through Fluorescence Resonance Energy Transfer (FRET) into emission from the fluorescent label and the amount of said FRET is affected by the binding of the analyte to the moiety; and, (iv) the emission from the fluorescent label is measured; whereby the level of emission from the fluorescent label is indicative of the presence of the analyte, and wherein the protein undergoes no substantial conformational charge during the method. A kit for carrying out the method of the invention and a protein are also provided.
    Type: Application
    Filed: September 21, 2006
    Publication date: June 10, 2010
    Applicants: LEIDEN UNIVERSITY, UNIVERSITY OF PADUA
    Inventors: Gerard W. Canters, Gerhild Zauner, Armand W.J.W. Tepper, Luigi Bubacco, Thijs J. Aartsma
  • Publication number: 20100144009
    Abstract: The present invention relates to the extraction and purification of lipoxygenase from plant matter, including soy beans. A process for purifying lipoxygenase from plant matter is provided.
    Type: Application
    Filed: December 20, 2007
    Publication date: June 10, 2010
    Inventors: Michael Patane, Akshat Talwalkar
  • Publication number: 20100143997
    Abstract: The present invention is generally provides recombinant microorganisms comprising engineered metabolic pathways capable of producing C3-C5 alcohols under aerobic and anaerobic conditions. The invention further provides ketol-acid reductoisomerase enzymes which have been mutated or modified to increase their NADH-dependent activity or to switch the cofactor preference from NADPH to NADH and are expressed in the modified microorganisms. In addition, the invention provides isobutyraldehyde dehydrogenase enzymes expressed in modified microorganisms. Also provided are methods of producing beneficial metabolites under aerobic and anaerobic conditions by contacting a suitable substrate with the modified microorganisms of the present invention.
    Type: Application
    Filed: November 2, 2009
    Publication date: June 10, 2010
    Inventors: Thomas Buelter, Peter Meinhold, Reid M. Renny Feldman, Eva Eckl, Andrew Hawkins, Aristos Aristidou, Catherine Asleson Dundon, Doug Lies, Sabine Bastian, Frances Arnold, Jun Urano
  • Patent number: 7731954
    Abstract: A skin dressing, particularly a wound dressing, comprises oxidoreductase enzyme and, optionally, peroxidase enzyme, wherein the enzyme(s) are present in hydrated condition, e.g. being present in one or more hydrated hydrogels. The dressing is used by being located on the skin of a human or animal e.g. over a wound. The oxidoreductase enzyme catalyses a reaction that produces hydrogen peroxide from an appropriate substrate, the substrate either being naturally present in body fluids and/or being supplied separately and/or being incorporated into the dressing. The currently preferred oxidoreductase enzyme is glucose oxidase. The catalyses reaction of ?-D-glucose substrate to give hydrogen peroxide and gluconic acid. A mixture of oxidoreductase enzyme can undergo reaction (optionally catalysed by the peroxidase enzyme) to produce a variety of species including reactive oxygen intermediates that have antimicrobial properties and that can therefore assist in promoting wound healing.
    Type: Grant
    Filed: April 23, 2003
    Date of Patent: June 8, 2010
    Assignee: Insense Limited
    Inventors: Paul James Davis, Andrew John Austin
  • Patent number: 7732177
    Abstract: The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: June 8, 2010
    Assignee: Illumigen Biosciences, Inc.
    Inventors: Shawn P. Iadonato, Charles L. Magness, Mark Branum, Maralee McVean, Christina Scherer
  • Patent number: 7732178
    Abstract: The present invention relates to novel laccase enzymes obtainable from the strains of the genus Thielavia or from the strains of the genus Chaetomium. The invention relates also to nucleic acid sequences encoding the enzymes, recombinant hosts into which the nucleic acid sequences have been introduced and to methods for the production of the enzymes in recombinant hosts. The enzymes of the invention are suitable for several applications, for example for treating denim and for strain removal.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: June 8, 2010
    Assignee: AB Enzymes Oy
    Inventors: Marja Paloheimo, Terhi Puranen, Leena Valtakari, Kristiina Kruus, Jarno Kallio, Arja Mantyla, Richard Fagerstrom, Pentti Ojapalo, Jari Vehmaanpera
  • Patent number: 7732161
    Abstract: The invention provides a biological method of producing isoprenoids.
    Type: Grant
    Filed: May 24, 2007
    Date of Patent: June 8, 2010
    Assignee: Bio-Technical Resources, a division of Arkion Life Sciences, LLC
    Inventors: James R. Millis, Julie Maurina-Brunker, Thomas W. McMullin
  • Patent number: 7727750
    Abstract: The present invention relates to biocatalytic asymmetric reduction for the preparation of 2-amino-[5-(1-hydroxy-2-hydroxy or halogen-ethyl)]-pyrazine derivatives of the formula wherein R is lower alkylcarbonyl or an amino protecting group and R1 is hydroxy or halogen. The compounds are key intermediates in the manufacture of a glucokinase activator.
    Type: Grant
    Filed: April 3, 2008
    Date of Patent: June 1, 2010
    Assignee: Hoffman-La Roche Inc.
    Inventors: Steven Paul Hanlon, Hans Iding, Ernst Kupfer, Roumen Nikolaev Radinov, Lianhe Shu, Ping Wang
  • Publication number: 20100129891
    Abstract: A heat-resistant bilirubin oxidase mutant is disclosed. The bilirubin oxidase mutant is obtained by deletion, replacement, addition or insertion of at least one amino acid residue of a wild type amino sequence of SEQ. ID. No. 1 of a bilirubin oxidase derived from an imperfect filamentous fungus, Myrothecium verrucaria. A biocathode including a thermo stable bilirubin oxidase mutant immobilized thereon, and its use in a biofuel cell is disclosed.
    Type: Application
    Filed: May 19, 2009
    Publication date: May 27, 2010
    Applicant: SONY CORPORATION
    Inventors: Hideyuki Kumita, Yuichi Tokita, Yoshio Goto
  • Patent number: 7723097
    Abstract: The invention relates to novel bacterial strains and constructs as well as methods for production of L-amino acids, including but not limited to L-threonine. Such novel bacterial strains may be characterized by, for instance, Escherichia coli strains in which an aspartate semialdehyde dehydrogenase (asd) gene is operably associated with at least one non-native promoter, non-native ribosome binding site, or both.
    Type: Grant
    Filed: March 9, 2006
    Date of Patent: May 25, 2010
    Assignee: Archer-Daniels-Midland Company
    Inventors: John N. D'Elia, Sean W. Jordan